EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Sputum Liquid Biopsy for Lung Cancer Screening, Diagnosis, Subtyping, Surveillance, Response Prediction, and Prognostication: A Scoping Review

Abdul Rehman iD, Muhammad Awais iD, Hafiza Noor Ul Ain Baloch iD, Muhammad Omer Leghari, Arfa Ahmad, Hafiz Javed

Medical Sciences · 30.04.2026 · 14 (2) · 231

DOI: 10.3390/medsci14020231 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Medical Sciences, online erschienen am 30.04.2026. Verfasst von Abdul Rehman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, TidalHealth Peninsula Regional, Salisbury, MD 21801, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Sputum, Early Detection of Cancer. Die Arbeit nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Liquid biopsy (LB) is transforming cancer care by enabling minimally invasive tumor profiling. While current research and clinical pathways mostly focus on blood LB, sputum represents a non-invasive, readily available respiratory specimen that may offer unique advantages for lung cancer (LC) care. Despite its potential, the maturity, breadth, and clinical applicability of sputum-based LB remain elusive.

Methods

We conducted a scoping review to systematically map the existing literature on sputum LB in LC. Electronic databases were searched for studies evaluating sputum-derived biomarkers—cytologic, genomic, epigenetic, transcriptomic, proteomic, metabolomic, metagenomic, and extracellular vesicle–derived products—across the LC care continuum. Study designs, technologies, clinical contexts, and reported outcomes were extracted and synthesized qualitatively.

Results

The literature demonstrated substantial heterogeneity in sputum collection, processing, and analytical platforms. Early work focused on cytometry and genetic alterations, while recent studies increasingly explore DNA methylomics, microRNAs, extracellular vesicle-derived products, and multi-omics approaches. The evidence suggests potential utility of sputum biomarkers for early detection and risk stratification, particularly in high-risk populations, with emerging data supporting roles in molecular subtyping, response monitoring, prognostication, and surveillance. However, few studies report prospective validation, direct comparison with blood-based LB, or impact on actual patient outcomes.

Conclusions

Sputum LB is a promising yet underdeveloped modality in LC care. This scoping review highlights technological innovations alongside significant methodological heterogeneity and translational gaps. Future research should focus on standardization, prospective validation, impact on patient outcomes, and integration with blood- and other body fluid–based LB, as well as imaging biomarkers. This will enable incorporation of sputum-based LB into actual clinical pathways of LC care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsSputumEarly Detection of CancerHumansLiquid BiopsyBiomarkers, TumorPrognosis

Stichwörter der Autor:innen

cell-free nucleic acidscirculating tumor DNAcirculating tumor cellsliquid biopsylung neoplasmsneoplasm genetic markerssputumtumor biomarkers

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medicine, TidalHealth Peninsula Regional, Salisbury, MD 21801, USA.
  • Department of Radiology, Aga Khan University Hospital, Karachi 74800, Sindh, Pakistan.

ORCID-Profile: Abdul Rehman, Muhammad Awais, Hafiza Noor Ul Ain Baloch

Zitieren

APA

Rehman, A., Awais, M., Baloch, H. N. U. A., Leghari, M. O., Ahmad, A., & Javed, H. (2026). Sputum Liquid Biopsy for Lung Cancer Screening, Diagnosis, Subtyping, Surveillance, Response Prediction, and Prognostication: A Scoping Review. Medical Sciences, 14(2), 231. https://doi.org/10.3390/medsci14020231

Vancouver

Rehman A, Awais M, Baloch HNUA, Leghari MO, Ahmad A, Javed H. Sputum Liquid Biopsy for Lung Cancer Screening, Diagnosis, Subtyping, Surveillance, Response Prediction, and Prognostication: A Scoping Review. Medical Sciences. 2026;14(2):231. doi:10.3390/medsci14020231

BibTeX
@article{Rehman2026,
  author = {Rehman, Abdul and Awais, Muhammad and Baloch, Hafiza Noor Ul Ain and Leghari, Muhammad Omer and Ahmad, Arfa and Javed, Hafiz},
  title = {Sputum Liquid Biopsy for Lung Cancer Screening, Diagnosis, Subtyping, Surveillance, Response Prediction, and Prognostication: A Scoping Review},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {2},
  pages = {231},
  doi = {10.3390/medsci14020231}
}
Kostenlos starten →